Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice

Acta Veterinaria Scandinavica

Volumn 52, Issue 1, 2010, Pages

  Shao, Meili ^a,b   Wang, Yong ^a   Wang, Chunlai ^a   Guo, Yang ^c   Peng, Yonggang ^a   Liu, Jiandong ^a   Li, Guangxing ^b   Liu, Huifang ^a   Liu, Siguo ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^c SHENYANG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINOBACILLUS PLEUROPNEUMONIAE; MUS; MYCOPLASMA; SUIDAE; SUS;

BACTERIAL TOXIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; RECOMBINANT PROTEIN; SUBUNIT VACCINE;

ACTINOBACILLUS INFECTION; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNIZATION; IMMUNOLOGY; MALE; METHODOLOGY; MICROBIOLOGY; MORTALITY; MOUSE; RANDOMIZATION; STANDARD; SWINE; SWINE DISEASE;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; BACTERIAL VACCINES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SWINE; SWINE DISEASES; VACCINES, SUBUNIT;

EID: 77956493151     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1751-0147-52-52     Document Type: Article

References (30)

1. Macinnes JL, Rosendal S. Prevention and control of Actinobacillus (Haemophilus) pleuropneumoniae infection in swine. Can J Vet Res 1988, 29:572-574.
2. Bosse JT, Johnson RP, Nemec M, Rosendal S. Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype1. Infect Immun 1992, 60:479-484. 257652, 1730479.
3. Stine DL, Fedorka-Cray PJ, Huether MJ, Gentry MJ, Anderson GA. Comparison of serum responses in swine after vaccination and challenge exposure with Actinobacillus pleuropneumoniae serotype 1. Am J Vet Res 1994, 55:1238-1243.
4. Fenwick BW, Cullor JS, Osburn BI, Olander HJ. Mechanisms involved in protection provided by immunization against core lipopolysaccharides of Escherichia coli J5 from lethal Haemophilus pleuropneumoniae infections in swine. Infect Immun 1986, 53:298-304. 260874, 3525407.
5. Haesebrouck F, Chiers K, Van Overbeke I, Ducatelle R. Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet Microbiol 1997, 58:239-249. 10.1016/S0378-1135(97)00162-4, 9453134.
6. Devenish J, Rosendal S, Bosse JT. Humoral antibody response and protective immunity in swine following immunization with the 104-kilodalton hemolysin of Actinobacillus pleuropneumoniae. Infect Immun 1990, 58:3829-3832. 313742, 2254012.
7. Bhatia B, Mittal KR, Frey J. Factors involved in immunity against Actinobacillus pleuropneumoniae in mice. Vet Microbiol 1991, 29:147-158. 10.1016/0378-1135(91)90122-V, 1746154.
8. Haga Y, Ogino S, Ohashi S, Ajito T, Hashimoto K, Sawada T. Protective efficacy of an affinity-purified hemolysin vaccine against experimental swine pleuropneumonia. The J Vet Med Sci 1997, 59:115-120.
9. van den Bosch H, Frey J. Interference of outer membrane protein PalA with protective immunity against Actinobacillu pleuropneumoniae infections in vaccinated pigs. Vaccine 2003, 21:3601-3607. 10.1016/S0264-410X(03)00410-9, 12922088.
10. Frey J, Bosse JT, Chang YF, Cullen JM, Fenwick B, Gerlach GF, Gygi D, Haesebrouck F, Inzana TJ, Jansen R, Kamp EM, Macdonald J, MacInnes JI, Mittal KR, Nicolet J, Rycroft AN, Segers RPAM, Smits MA, Stenbaek E, Struck DK, Van den Bosch JF, Wilson PJ, Young R. Actinobacillu pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, Pleurotoxin and their genes. J Gen Microbiol 1993, 139:1723-1728.
11. Goethe R, Gonzáles OF, Lindner T, Gerlach GF. A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction. Vaccine 2001, 19(7-8):966-975.
12. Byrd W, Harmon BG, Kadis S. Protective efficacy of conjugate vaccines against experimental challenge with porcine Actinobacillus pleuropneumoniae. Vet Immunol Immunopathol 1992, 34:307-324. 10.1016/0165-2427(92)90172-M, 1455686.
13. Kobisch M, Bosch JF. Efficacy of an Actinobacillus pleuropneumoniae subunit vaccine. Proceedings of the International Pig Veterinary Society Congress, The Hague, The Netherlands 1992, 216.
14. Martelli P, Guadagnini PF, Foccoli E, Ballarini G. Efficacy of an Actinobacillus pleuropneumoniae subunit vaccine in the control of pleuropneumonia: a field trial. Proceeding of the International Pig Veterinary Society (IPVS) Congress, Bologna, Italy 1996, 214.
15. Attridge S, Voss E, Manning PA. Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor. J Biotechnol 1999, 73:109-117. 10.1016/S0168-1656(99)00114-5, 10486921.
16. Sauer FG, Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bacterial pili:molecular mechanisms of pathgenesis. Curr Opin Microbiol 2000, 3:65-72. 10.1016/S1369-5274(99)00053-3, 10679419.
17. Doughty SW, Ruffolo CG, Adler B. The type 4 fimbial subunit gene of Pasteurella multocida. Vet Microbiol 2000, 72:79-90. 10.1016/S0378-1135(99)00189-3, 10699505.
18. Altboum Z, Levine MM, Galen JE, Barry EM. Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain. Infect Immun 2003, 71:1352-1360. 10.1128/IAI.71.3.1352-1360.2003, 148885, 12595452.
19. Wu JY, Wade WF, Taylor RK. Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice. Infect Immun 2001, 69:7695-7702. 10.1128/IAI.69.12.7695-7702.2001, 98864, 11705950.
20. Zhang YM, Ingham A, Beddome G, Prideaux C, Michalski WP, Tennent JM. Identification of type 4 fimbriae in Actinobacillus pleuropneumoniae. FEMS Microbiol Lett 2000, 189(9-10):15-18. 10.1111/j.1574-6968.2000.tb09199.x, 10913859.
21. Sthitmatee N, Sirinarumitr T, Makonkewkeyoon L, Sakpuaram T, Tesaprateep T. Identification of the Actinobacillus pleuropneumoniae serotype using PCR based-apx genes. Mol Cell Probes 2003, 17(6):301-305. 10.1016/j.mcp.2003.08.001, 14602481.
22. Schaller A, Kuhn R, Kuhnert P, Nicolet J, Anderson TJ, MacInnes JI, Segers RP, Frey J. Characterization of ApxIV, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology 1999, 145:2105-2116. 10.1099/13500872-145-8-2105, 10463177.
23. Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual. 2001, 810-814. Cold Spring Harbour, NY, Cold Spring Harbour Laboratory Press, third.
24. Nielsen R, van den Bosch JF, Plambeck T, Sorensen V, Nielsen JP. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodied to the Apx toxins of Actinobacillus pleuropneumoniae. Vet Microbiol 2000, 71:81-87. 10.1016/S0378-1135(99)00157-1, 10665536.
25. Weyant RS, Bibb WF, Stephens DS, Holloway BP, Moo-Penn WF, Birkness KA, Helsel LO, Mayer LW. Purification and characterization of a pilin specific for brazilian purpuric fever-associated Haemophilus influenzae biogroup aegyptius strains. J Clin Microbiol 1990, 28:756-763. 267789, 1970577.
26. Besudet R, Mcsween G, Boulay G, Rousseau P, Bisaillon JG, Descoteaux JP, Ruppanner R. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination. Vet Microbiol 1994, 39:71-81. 10.1016/0378-1135(94)90087-6, 8203129.
27. Furesz SE, Mallard BA, Bosse JT, Rosendal S, Wilkie BN, Macinnes JI. Antibody and cell-mediated immune responses of Actinobacillus pleuropneumoniae infected and bacterin-vaccinated pigs. Infect Immun 1997, 65:358-365. 174603, 9009283.
28. Liao CW, Chiou HY, Yeh KS, Chen JR, Weng CN. Oral immunization using formalin-inactivated entrapped in microspheres with aqueous dispersion polymers prepared using a co-spray drying process. Prevent Vet Med 2003, 61:1-15.
29. Jolley KA, Appleby L, Wright JC, Christodoulides M, Heckels JE. Immunisation with recombinant Opc outer membrane protein from Neisseria meningitidis: influence of sequence variation and levels of expression on the bactericidal immune response against meningococci. Infect Immun 2001, 69:3809-3816. 10.1128/IAI.69.6.3809-3816.2001, 98398, 11349046.
30. Wang CL, Wang Y, Shao ML, Si W, Liu HF, Chang YH, Peng W, Kong XG, Liu SG. Positive role for rApxIVN in the immune protection of pigs against in fection by Actinobacilluspleuropneumoniae. Vaccine 2009, 27:5816-5821. 10.1016/j.vaccine.2009.07.065, 19654060.